Treatment of autoimmune mucocutaneous blistering diseases with intravenous immunoglobulin therapy

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.8, 2004-08, pp. : 1019-1032

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Treatment of Autoimmune Blistering Diseases

Current Drug Discovery Technologies, Vol. 6, Iss. 4, 2009-12 ,pp. : 270-280

Bentham Science Publishers

Access to resources Recommend Favorite

Intravenous immunoglobulin therapy for the treatment of severe atopic dermatitis

By Lamb S.R. Rademaker M.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 1, 2001-01 ,pp. : 67-74

Informa Healthcare

Access to resources Recommend Favorite

Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-01 ,pp. : 4570-4582

Bentham Science Publishers

Access to resources Recommend Favorite

Intravenous Immunoglobulin Preparations and Autoimmune Disorders: Mechanisms of Action

Current Pharmaceutical Biotechnology, Vol. 4, Iss. 4, 2003-08 ,pp. : 239-247

Bentham Science Publishers

Access to resources Recommend Favorite

Adverse Effects of Intravenous Immunoglobulin Therapy

By Nydegger U.E.

Drug Safety, Vol. 21, Iss. 3, 1999-09 ,pp. : 171-185

Adis International

Access to resources Recommend Favorite